美国FDA监管的临床试验与FDA监管的临床试验. 现实世界的数据:如何弥合疼痛研究的差距
Anthony Reyes1,2, Mohummed Malik2, Malik Sahouri2
1Department of Physical Medicine and Rehabilitation, Rush University Medical Center, Chicago, IL 60612, USA.
Brain sciences
|October 29, 2025
概括
随机对照试验 (RCT) 和现实世界数据 (RWD) 为慢性疼痛治疗提供了互补的见解. 整合两者可以弥合疗效差距,以获得更好的以患者为中心的护理.
科学领域:
- 疼痛医学 医学 疼痛医学
- 临床试验设计 临床试验设计
- 医疗信息学 医疗信息学
背景情况:
- 随机对照试验 (RCT) 是评估慢性疼痛治疗的标准,但由于严格的设计和精选人群,其在现实世界的适用性受到限制.
- 从各种来源收集的真实世界数据 (RWD) 提供了对治疗坚持和安全的洞察力,这些数据往往被RCT遗漏.
- 疗效差距突出了对照试验结果与慢性疼痛管理中的实际患者结果之间的差异.
研究的目的:
- 从FDA监管的RCT和RWD中确定适用于常规慢性疼痛管理的因素.
- 加强日常临床实践,以获得更全面,更以患者为中心的慢性疼痛护理.
- 整合RCT和RWD为支持临床决策和指导方针的综合证据基础.
主要方法:
- 对食品和药物管理局 (FDA) 监管的随机对照试验 (RCT) 中使用的因素的审查.
- 在现实世界数据 (RWD) 收集中分析数据源 (例如,电子健康记录,注册表,索赔数据库,数字健康平台).
- 在慢性疼痛管理中确定RCT方法和RWD之间的潜在整合点.
主要成果:
- 电竞试验提供了可靠的疗效数据,但缺乏现实世界的背景.
- RWD提供了关于坚持,安全和多样化的患者群体的见解.
- 在慢性疼痛治疗结果中存在显著的疗效差距.
- 需要整合策略来利用RCT和RWD.
结论:
- 结合RCT和RWD可以为慢性疼痛管理创建更全面的证据基础.
- 弥合疗效差距对于使治疗结果与患者目标保持一致至关重要.
- 实施已识别的因素可以导致更加以患者为中心和公平的慢性疼痛护理.
相关概念视频
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
397
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
397
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


